3JDG3 : JGL d.d.-dosp 12/2029/A

Trading

Previously Traded

Date
-

Close Price
-

Volume
-

Turnover
-

Last 52 weeks

High Price
-

Low Price
-

There were no trades with this instrument

Order Book

#	Volume	Price		Volume	#
Bid			Ask

Trading is closed

Instrument

ISIN
HRJDGLO29CA5

FISN
JGL/4.125BD 20291203 1 UNSEC

Type
Corporate Bond

CFI Code
DBFUFR

Issue Date
12/03/2024

Maturity Date
12/03/2029

Nominal Value
1.00 EUR

Interest Rate
4.1250 %

Payout Period
6 months

Prospectus
View Prospectus

Symbol
3JDG3

MIC
XZAG

Segment
Official market

Trading Model
Continuous Trading

First Trading Day
12/06/2024

Listed Quantity
60,000,000

Market Cap
60.66 mil. EUR

Last Trading Day
11/28/2029

Industry

Sector
CF · Manufacture of basic pharmaceutical products and pharmaceutical preparations

NACE
2120 · Manufacture of pharmaceutical preparations

Trading Parameters

Min Order Quantity
1

Min Block Value
1,500,000.00 EUR

Iceberg Orders

Min Total Value
10,000.00 EUR

Min Peak Value
500.00 EUR (5 %)

Trading Safeguards

Max Order Size
20,000,000

Max Order Value
2,000,000.00 EUR

Volatility Interruptions

Category
D2

Dynamic Corridor
± 15 %

Static Corridor
± 30 %

Extended Volatility
± 45 %

Ownership Structure

Učitavanje…

Loading, please wait No matching records found

Seq.no.	Account owner (holder) / Security co-holder (holder)	% share
1	PRIVREDNA BANKA ZAGREB D.D./PRIVREDNA BANKA ZAGREB D.D.	26.92 %
2	ZAGREBAČKA BANKA D.D./EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT	16.67 %
3	ERSTE & STEIERMARKISCHE BANK D.D./ERSTE & STEIERMARKISCHE BANK D.D.	14.88 %
4	OTP BANKA D.D./OTP BANKA D.D.	8.17 %
5	ERSTE & STEIERMARKISCHE BANK D.D./PBZ CO OMF - KATEGORIJA A	5.00 %
6	PODRAVSKA BANKA D.D./PODRAVSKA BANKA D.D.	4.50 %
7	RAIFFEISENBANK AUSTRIA D.D./RAIFFEISEN DOBROVOLJNI MIROVINSKI FOND	4.00 %
8	HPB D.D./FOND ZA FINANCIRANJE RAZGRADNJE NEK	3.33 %
9	ERSTE & STEIERMARKISCHE BANK D.D./PBZ CO OMF - KATEGORIJA B	3.33 %
10	PRIVREDNA BANKA ZAGREB D.D./RAIFFEISEN OMF KATEGORIJE A	2.29 %

Account owner (holder) / Security co-holder (holder)
% share

PRIVREDNA BANKA ZAGREB D.D./PRIVREDNA BANKA ZAGREB D.D.
26.92

ZAGREBAČKA BANKA D.D./EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT
16.67

ERSTE & STEIERMARKISCHE BANK D.D./ERSTE & STEIERMARKISCHE BANK D.D.
14.88

OTP BANKA D.D./OTP BANKA D.D.
8.17

ERSTE & STEIERMARKISCHE BANK D.D./PBZ CO OMF - KATEGORIJA A
5.00

PODRAVSKA BANKA D.D./PODRAVSKA BANKA D.D.
4.50

RAIFFEISENBANK AUSTRIA D.D./RAIFFEISEN DOBROVOLJNI MIROVINSKI FOND
4.00

HPB D.D./FOND ZA FINANCIRANJE RAZGRADNJE NEK
3.33

ERSTE & STEIERMARKISCHE BANK D.D./PBZ CO OMF - KATEGORIJA B
3.33

PRIVREDNA BANKA ZAGREB D.D./RAIFFEISEN OMF KATEGORIJE A
2.29

Issuer

JADRAN - GALENSKI LABORATORIJ d. d.

Home Member State
Hrvatska (Croatia)

Address
Svilno 20

City
51000 Rijeka

Internet Address
www.jgl.hr

Contact Person
Katja Cofek Pervan

Contact Phone
051/660 700

Contact E-mail
jgl@jglpharma.com

Share Capital
16,589,677.00 EUR

LEI
529900NRAH6YWL3TLD24

Tax Number
20950636972

JGL is the largest domestic pharmaceutical company in Croatia with a leading global position in three key therapeutic areas – flu and cold, ophthalmology and dermatology. Over 30 years, JGL has been growing and developing business around the world, and thanks to constant investment in research and development, production facilities and hi-tech technology, in accordance with ESG business principles, the company ranks among the leading producers of sterile pharmaceutical forms in the EU.

Aqua Maris, as a leading brand of the company was launched in 1999 and consists of 100 percent natural products based on seawater from the Adriatic Sea for the prevention and treatment of Upper respiratory tract infections. These are the first medicinal products in the world proven to be free of microplastics. Other key brands are Vizol S, Meralys, Aknekutan and Dramina.

More information is available on our website: www.jgl.hr

All Listed Instruments